Cover Image

Making better drugs for children with cancer /

Corporate Author: National Cancer Policy Board (U.S.). Committee on Shortening the Time Line for New Cancer Treatments.
Other Authors: Adamson, Peter C.
Format: Book
Language:English
Published: Washington, D.C. : National Academies Press, ©2005.
Subjects:
Drug approval > United States.
Cancer in children > Chemotherapy.
Neoplasms > drug therapy.
Antineoplastic Agents.
Child.
Clinical Trials.
Drug Approval.
Neoplasms > epidemiology.
Antineoplastic agents.
Oncology.
MEDICAL > Drug Guides.
MEDICAL > Pharmacology.
MEDICAL > Pharmacy.
MEDICAL > Nursing
United States.
Online Access:http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=131249
LEADER 02080nam a2200397 a 4500
001 1899818
005 20171111234732.0
008 050504s2005 dcua ob 000 0 eng d
020 |a 0309549256  |q (electronic bk.) 
020 |a 9780309549257  |q (electronic bk.)  |z 0309096081  |q (pbk.)  |q (pbk.) 
040 |a N$T  |b eng  |e pn  |z 9780309096089 
050 4 |a RA401.5  |b .N38 2005eb 
245 0 0 |a Making better drugs for children with cancer /  |c Committee on Shortening the Time Line for New Cancer Treatments, National Cancer Policy Board ; Peter C. Adamson [and others], editors ; Institute of Medicine and National Research Council of the National Academies. 
260 |a Washington, D.C. :  |b National Academies Press,  |c ©2005. 
300 |a 1 online resource (xiv, 42 pages) :  |b illustrations 
504 |a Includes bibliographical references. 
505 0 |a Childhood cancers: Background -- Agents in use and in testing for children with cancer -- The existing capacity for developing new agents specifically for childhood cancers -- Putting the pieces together -- Delays in testing approved agents in children -- The need to prioritize agents for testing in children with cancer -- Testing and labeling of drugs for pediatric use. 
650 0 |a Drug approval  |z United States. 
650 0 |a Cancer in children  |x Chemotherapy. 
650 1 2 |a Neoplasms  |x drug therapy. 
650 2 2 |a Antineoplastic Agents. 
650 2 2 |a Child. 
650 2 2 |a Clinical Trials. 
650 2 2 |a Drug Approval. 
650 2 2 |a Neoplasms  |x epidemiology. 
650 4 |a Antineoplastic agents. 
650 4 |a Oncology. 
650 7 |a MEDICAL  |x Drug Guides. 
650 7 |a MEDICAL  |x Pharmacology. 
650 7 |a MEDICAL  |x Pharmacy. 
650 7 |a MEDICAL  |x Nursing 
651 2 |a United States. 
700 1 |a Adamson, Peter C.  |x Pharmacology. 
710 2 |a National Cancer Policy Board (U.S.).  |b Committee on Shortening the Time Line for New Cancer Treatments. 
856 4 0 |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=131249 
952 |a CY-NiOUC  |b 5a04659c6c5ad14ac1eed5b1  |c 998a  |d 945l  |e -  |t 1  |x m  |z Books 

Similar Items